Oculus Innovative Sciences, Inc. Receives "Strong Consensus" Rating For Use With Kinetic Concepts, Inc.' Negative Pressure Wound Therapy With Instillation

PETALUMA, Calif., April 9, 2014 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), a global healthcare company that designs, manufactures and markets prescription and non-prescription products in 33 countries, today announced that the company's Microcyn® Negative-Pressure Wound Therapy Solution™ received a "strong consensus" rating for use with Kinetic Concepts Inc.'s (KCI) Negative Pressure Wound Therapy with Instillation (NPWTi) as identified in the First International Consensus Guidelines.

Help employers find you! Check out all the jobs and post your resume.